Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Appointed director
SANGAMO THERAPEUTICS, INC (SGMO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13G/A WASATCH ADVISORS LP reports a 10.2% stake in Sangamo Therapeutics, Inc.
02/09/2023 SC 13G/A WASATCH ADVISORS INC reports a 7.7% stake in Sangamo Therapeutics, Inc.
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.6% stake in Sangamo Therapeutics Inc.
02/07/2023 SC 13G/A STATE STREET CORP reports a 6% stake in AMENDED FILING SANGAMO THERAPEUTICS INC
01/24/2023 SC 13G/A BlackRock Inc. reports a 9.4% stake in SANGAMO THERAPEUTICS INC
02/10/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A VANGUARD GROUP INC reports a 6.4% stake in Sangamo Therapeutics Inc.
02/01/2022 SC 13G/A BlackRock Inc. reports a 8% stake in SANGAMO THERAPEUTICS INC
02/11/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G/A VANGUARD GROUP INC reports a 6% stake in Sangamo Therapeutics Inc.
02/04/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/01/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2020 SC 13G/A STATE STREET CORP reports a 4.2% stake in EXIT FILING Sangamo Therapeutics Inc
02/12/2020 SC 13G/A VANGUARD GROUP INC reports a 7.3% stake in Sangamo Therapeutics Inc
02/13/2019 SC 13G/A FMR LLC reports a 2.4% stake in SANGAMO THERAPEUTICS INC
02/13/2019 SC 13G/A VANGUARD GROUP INC reports a 7.4% stake in Sangamo Therapeutics Inc
02/06/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018 SC 13G/A ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 2.8% stake in Sangamo Therapeutics, Inc.
02/05/2018 SC 13G/A WASATCH ADVISORS INC reports a 4.6% stake in Sangamo Biosciences Inc.
01/23/2018 SC 13G/A BlackRock Inc. reports a 8.1% stake in SANGAMO THERAPEUTICS INC
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
01/26/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/13/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/08/2011 SC 13G/A SANGAMO BIOSCIENCES INC reports a 6.4% stake in SANGAMO BIOSCIENCES INC
01/12/2009 SC 13G/A BLAIR WILLIAM & CO reports a 3.4% stake in SANGAMO BIOSCIENCES
12/10/2008 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy